Evaluation of FES (16α-[18F]-fluoro-17β-estradiol) PET for (re)staging of patients with clinical (locally) advanced or locoregional recurrent estrogen receptor positive breast cancer

R. Iqbal; C. Mo; M. C. F. Cysouw; A. W. J. M. Glaudemans; G. A. P. Hospers; C. P. Schroder; C. C. M. Venema; C. W. Menke-van der Houven van Oordt

doi:https://doi.org/10.1016/S0959-8049(20)30770-X

Evaluation of FES (16α-[18F]-fluoro-17β-estradiol) PET for (re)staging of patients with clinical (locally) advanced or locoregional recurrent estrogen receptor positive breast cancer

R. Iqbal, C. Mo, M. C. F. Cysouw, A. W. J. M. Glaudemans, G. A. P. Hospers, C. P. Schroder, C. C. M. Venema, C. W. Menke-van der Houven van Oordt

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	S88
Journal	European Journal of Cancer
Volume	138
DOIs	https://doi.org/10.1016/S0959-8049(20)30770-X
Publication status	Published - 1 Oct 2020

Access to Document

https://doi.org/10.1016/S0959-8049(20)30770-X

Cite this

Iqbal, R., Mo, C., Cysouw, M. C. F., Glaudemans, A. W. J. M., Hospers, G. A. P., Schroder, C. P., Venema, C. C. M., & Menke-van der Houven van Oordt, C. W. (2020). Evaluation of FES (16α-[18F]-fluoro-17β-estradiol) PET for (re)staging of patients with clinical (locally) advanced or locoregional recurrent estrogen receptor positive breast cancer. European Journal of Cancer, 138, S88. https://doi.org/10.1016/S0959-8049(20)30770-X

@article{fbfc4620d3194706986836143c4827d1,

title = "Evaluation of FES (16α-[18F]-fluoro-17β-estradiol) PET for (re)staging of patients with clinical (locally) advanced or locoregional recurrent estrogen receptor positive breast cancer",

author = "R. Iqbal and C. Mo and Cysouw, {M. C. F.} and Glaudemans, {A. W. J. M.} and Hospers, {G. A. P.} and Schroder, {C. P.} and Venema, {C. C. M.} and {Menke-van der Houven van Oordt}, {C. W.}",

year = "2020",

month = oct,

day = "1",

doi = "https://doi.org/10.1016/S0959-8049(20)30770-X",

language = "English",

volume = "138",

pages = "S88",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier Limited",

}

Iqbal, R, Mo, C, Cysouw, MCF, Glaudemans, AWJM, Hospers, GAP, Schroder, CP, Venema, CCM & Menke-van der Houven van Oordt, CW 2020, 'Evaluation of FES (16α-[18F]-fluoro-17β-estradiol) PET for (re)staging of patients with clinical (locally) advanced or locoregional recurrent estrogen receptor positive breast cancer', European Journal of Cancer, vol. 138, pp. S88. https://doi.org/10.1016/S0959-8049(20)30770-X

Evaluation of FES (16α-[18F]-fluoro-17β-estradiol) PET for (re)staging of patients with clinical (locally) advanced or locoregional recurrent estrogen receptor positive breast cancer. / Iqbal, R.; Mo, C.; Cysouw, M. C. F. et al.
In: European Journal of Cancer, Vol. 138, 01.10.2020, p. S88.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Evaluation of FES (16α-[18F]-fluoro-17β-estradiol) PET for (re)staging of patients with clinical (locally) advanced or locoregional recurrent estrogen receptor positive breast cancer

AU - Iqbal, R.

AU - Mo, C.

AU - Cysouw, M. C. F.

AU - Glaudemans, A. W. J. M.

AU - Hospers, G. A. P.

AU - Schroder, C. P.

AU - Venema, C. C. M.

AU - Menke-van der Houven van Oordt, C. W.

PY - 2020/10/1

Y1 - 2020/10/1

UR - http://www.scopus.com/inward/record.url?scp=85091948667&partnerID=8YFLogxK

U2 - https://doi.org/10.1016/S0959-8049(20)30770-X

DO - https://doi.org/10.1016/S0959-8049(20)30770-X

M3 - Article

SN - 0959-8049

VL - 138

SP - S88

JO - European Journal of Cancer

JF - European Journal of Cancer

ER -

Evaluation of FES (16α-[18F]-fluoro-17β-estradiol) PET for (re)staging of patients with clinical (locally) advanced or locoregional recurrent estrogen receptor positive breast cancer

Access to Document

Other files and links

Cite this